# Quality of Life and Psychiatric Comorbidities among Subjects Practicing Artificial Skin Depigmentation in 2020 in the City of Cotonou (Benin)

**Authors:** B. Degboe, M. M. D Baloubi, N. Ntouala Noukayaba, F. G. Akpadjan, H. Adegbidi, F. Atadokpede

PMC · DOI: 10.1155/2024/8589329 · Dermatology Research and Practice · 2024-04-23

## TL;DR

This study found that people in Cotonou who use skin depigmentation products often experience poor quality of life and mental health issues like anxiety and depression.

## Contribution

The study provides new insights into the mental health and quality of life impacts of artificial skin depigmentation in Cotonou.

## Key findings

- 93.7% of subjects had impaired quality of life.
- Anxiety and depression were diagnosed in 11.2% and 5.8% of subjects, respectively.
- Quality of life and mental health issues were linked to the number of skin lesions and use of depigmentation products.

## Abstract

The purpose of this study was to study the quality of life and psychiatric comorbidities of subjects practicing voluntary skin depigmentation in the city of Cotonou.

A cross-sectional, prospective, and analytical study, based on a three-stage probabilistic sampling method, included from June to October 2020, consenting subjects over 15 years of age, practicing artificial skin depigmentation, and residing for at least one year in Cotonou. The Dermatology Life Quality Index, Rosenberg, and Hospital Anxiety and Depression scales allowed us to evaluate the quality of life and self-esteem, and identify anxiety and depression, respectively. A p value <0.05 indicated a significant result.

We included 330 subjects. The mean age was 33.6 ± 11.6 years and the sex ratio was 0.4. Impaired quality of life was observed in 93.7% of subjects. Anxiety was diagnosed in 11.2% and depression in 5.8% of them. Self-esteem was low or very low in 24.2%. The degree of quality of life and the alteration of self-esteem, and the frequency of anxiety and depression were proportional to the number of skin lesions, the lightening products used, and the monthly cost of the products.

The use of several lightening products exposes patients to numerous skin lesions, which are a source of impaired quality of life and whose persistence leads to psychiatric comorbidities.

## Linked entities

- **Diseases:** anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Diseases:** Impaired quality of life (MESH:D003643), Artificial Skin Depigmentation (MESH:D012871), Depression (MESH:D003866), Anxiety (MESH:D001007), Psychiatric Comorbidities (MESH:D001523)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11074880/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11074880/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC11074880/full.md

---
Source: https://tomesphere.com/paper/PMC11074880